Abstract:Key PointsThe blood–brain barrier (BBB), which is formed by the endothelial cells that line cerebral microvessels, has an important role in maintaining a precisely regulated microenvironment for reliable neuronal signalling. There is great interest in the association of brain microvessels, astrocytes and neurons to form functional 'neurovascular units', and recent studies have highlighted the importance of brain endothelial cells in this modular organization.Three barrier layers limit and regulate molecular exchange at the interfaces between the blood and the neural tissue or its fluid spaces: the BBB between the blood and brain interstitial fluid, the choroid plexus epithelium between the blood and ventricular cerebrospinal fluid (CSF), and the arachnoid epithelium between the blood and subarachnoid CSF. Of these, the BBB exerts the greatest control over the immediate microenvironment of brain cells.The BBB acts as a 'physical barrier' because complex tight junctions between adjacent endothelial cells force most molecular traffic to take a transcellular route. The presence of specific transport systems on the luminal and abluminal membranes regulates transcellular traffic, providing a selective 'transport barrier', and a combination of intracellular and extracellular enzymes allows the BBB to serve as a 'metabolic barrier'.The BBB facilitates the entry of required nutrients into the brain, and excludes or effluxes potentially harmful compounds. It helps to keep separate the pools of neurotransmitters and neuroactive agents that act centrally and peripherally, and it regulates the ionic microenvironment of neurons.Several features distinguish brain endothelium from the endothelium of most other tissues. In particular, the tight junctions are tighter and more complex in the brain endothelium. Among the molecules identified as making important contributions to tight junction structure are the transmembrane proteins occludin and the claudins. The brain endothelium also expresses several specific transport proteins at relatively high levels.Brain capillaries are surrounded by or closely associated with several cell types, including neuronal processes and the perivascular endfeet of astrocytic glia, so it is not surprising to find synergistic inductive functions involving more than one cell type. For example, astrocytes secrete a range of factors that can induce aspects of the BBB phenotype in endothelial cells in vitro, and brain endothelium enhances the growth and differentiation of associated astrocytes.Transmitters and modulators released by neurons, astrocytes and endothelium allow complex signalling between cells in the neurovascular unit, and many features of the BBB phenotype are subject to modulation under physiological or pathological conditions. For example, opening of the BBB's tight junctions may occur under normal conditions to allow the passage of growth factors and antibodies into the brain, and in inflammation can contribute to brain oedema.Astrocytes occupy a strategic position between capillaries and neurons. Those that form perivascular endfeet at the BBB have a special role in ionic, amino acid, neurotransmitter and water homeostasis of the brain.There is increasing evidence that the function of the BBB is altered in several neuropathologies, including brain oedema, epilepsy, Alzheimer's disease and Parkinson's disease. Damage to the endothelium could allow the expression of endothelial receptors that are normally downregulated, opening new communication loops between endothelium, pericytes, astrocytes and microglia that are important in barrier repair.Reducing, halting or reversing BBB dysfunction could be of therapeutic value in conditions in which neuronal damage is secondary to or exacerbated by BBB damage. Moreover, maintaining endothelial health has the potential to delay or prevent the development of chronic neurodegeneration.

Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes

Cerebral Vascular Injury In Diabetic Ischemia And Reperfusion

Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition

Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics

Blood-brain barrier-morphology, modulation and clinical implications

Hyperglycaemia perturbs blood-brain barrier integrity through its effects on endothelial cell characteristics and function

Blood Brain Barrier Disruption in Diabetic Stroke Related to Unfavorable Outcome

Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease

The blood-brain barrier in health and chronic neurodegenerative disorders

Inhibition of Endoplasmic Reticulum Stress Preserves the Integrity of Blood-Spinal Cord Barrier in Diabetic Rats Subjected to Spinal Cord Injury

Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases

Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles

Upregulation of C1QC as a Mediator of Blood–Brain Barrier Damage in Type 2 Diabetes Mellitus

NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9

Revealing the mechanisms of blood-brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention

Astrocyte–endothelial interactions at the blood–brain barrier

Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease

Effects of Diabetes Mellitus-Related Dysglycemia on the Functions of Blood-Brain Barrier and the Risk of Dementia

Endothelial Dysfunctions in Blood–Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies

Blood-brain barrier dysfunction in ischemic stroke and diabetes: the underlying link, mechanisms and future possible therapeutic targets

Damage to the blood‐brain barrier and activation of neuroinflammation by focal cerebral ischemia under hyperglycemic condition